ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.1
  1. ホーム
  2. /反応

Cesium carbonate → 6-{4-[4-(5-chloro-1H-indole-2-sulphonyl)-piperazine-1-carbonyl]-phenyl}-2-(2-dimethylamino-ethyl)-2H-pyridazin-3-one

HRID 28398
印刷

反応式

HRID 28398 の反応式
Cl[C:2]1[CH:3]=[CH:4][C:5](=[O:13])[N:6]([CH2:8][CH2:9][N:10]([CH3:12])[CH3:11])[N:7]=1.C(=O)([O-])[O-].[Cs+].[Cs+].[Cl:20][C:21]1[CH:22]=[C:23]2[C:27](=[CH:28][CH:29]=1)[NH:26][C:25]([S:30]([N:33]1[CH2:38][CH2:37][N:36]([C:39]([C:41]3[CH:46]=[CH:45][C:44](B(O)O)=[CH:43][CH:42]=3)=[O:40])[CH2:35][CH2:34]1)(=[O:32])=[O:31])=[CH:24]2>COCCOC.O.C(O)C.C1(C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)[Pd][P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1>[Cl:20][C:21]1[CH:22]=[C:23]2[C:27](=[CH:28][CH:29]=1)[NH:26][C:25]([S:30]([N:33]1[CH2:34][CH2:35][N:36]([C:39]([C:41]3[CH:42]=[CH:43][C:44]([C:2]4[CH:3]=[CH:4][C:5](=[O:13])[N:6]([CH2:8][CH2:9][N:10]([CH3:12])[CH3:11])[N:7]=4)=[CH:45][CH:46]=3)=[O:40])[CH2:37][CH2:38]1)(=[O:31])=[O:32])=[CH:24]2
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 10796Cesium carbonateHCID 693065836-Chloro-2-(2-(dimethylamino)ethyl)pyridazin-3(2H)-oneHCID 693073894-({4-[(5-chloro-1H-indol-2-yl)sulphonyl]piperazin-1-yl}carbonyl)phenyl boronic acid

生成物 1

HCID 113765326-{4-[4-(5-chloro-1H-indole-2-sulphonyl)-piperazine-1-carbonyl]-phenyl}-2-(2-dimethylamino-ethyl)-2H-pyridazin-3-one収率 60.7%

試薬・触媒・溶媒 2

HCID 178419050
HCID 178419050、化合物
触媒
HCID 86587095Dimethoxyethane ethanol water溶媒

反応条件

温度
150 °C

実験手順

6-Chloro-2-(2-dimethylamino-ethyl)-2H-pyridazin-3-one (76 mg, 0.38 mmol), cesium carbonate (122 mg, 0.38 mmol) and bis(triphenylphosphine)palladium II chloride (21.9 mg, 0.03 mmol) was added to a microwave vial. The vial was evacuated and filled with argon twice. 4-({4-[(5-Chloro-1H-indol-2-yl)sulphonyl]piperazin-1-yl}carbonyl)phenyl boronic acid (140 mg, 0.31 mmol) dissolved in 4 mL 1,2-di-methoxyethane/water/ethanol (7:3:2) was added and the vial was once again evacuated and filled with argon. The reaction mixture was heated at 150° C. for 100 seconds, filtrated and purified by preparative HPLC using a gradient of acetonitrile/5% acetonitrile-water phase containing 0.1M ammonium acetate, to give 107 mg of 6-{4-[4-(5-chloro-1H-indole-2-sulphonyl)-piperazine-1-carbonyl]-phenyl}-2-(2-dimethylamino-ethyl)-2H-pyridazin-3-one after evaporation and freeze drying over night (60% yield).

後処理

  1. customThe vial was evacuated
  2. additionfilled with argon twice
  3. additionwas added
  4. customthe vial was once again evacuated
  5. additionfilled with argon
  6. filtrationfiltrated
  7. custompurified by preparative HPLC
  8. additioncontaining 0.1M ammonium acetate

出典と根拠

ORDレコード
ord-aea1d9dadd1a420a85b7a6d8f88c0541
出典データセット
uspto-grants-2008_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07419979B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート